The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Glycolysis module activated by hypoxia-inducible factor 1α is related to the aggressive phenotype of hepatocellular carcinoma1992 · 135 citations
2. 2Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance2019 · 148 citations
3. 3Metabolism‐induced tumor activator 1 (MITA1), an Energy Stress–Inducible Long Noncoding RNA, Promotes Hepatocellular Carcinoma Metastasis2019 · 106 citations
4. 4Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis2019 · 261 citations
5. 5Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1–Parkin pathway and modulate cellular drug response2017 · 108 citations